Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

Background: Infusion reactions (IRs) are the most common adverse events (AEs) of infliximab (IFX) treatment in patients with inflammatory bowel disease (IBD). Prophylactic premedication (PM) with corticosteroids or antihistamines prior to IFX infusions has been used in clinical practice, but its eff...

Full description

Bibliographic Details
Main Authors: Edyta Szymanska, Maciej Dadalski, Joanna Sieczkowska-Golub, Dorota Jarzebicka, Monika Meglicka, Marcin Osiecki, Anna Wiernicka, Dariusz M. Lebensztejn, Bartosz Korczowski, Jaroslaw Kierkus
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
premedication
infusion reaction
infliximab
inflammatory bowel disease
Online Access:https://www.mdpi.com/2077-0383/10/14/3177

Internet

https://www.mdpi.com/2077-0383/10/14/3177

Similar Items